The Edinburgh firm behind a digital pen which helps diagnose and treat people with neuromotor medical conditions has signed a five-year deal with stationery brand Stabilo.
The pen developed by Manus Neurodynamica combines with the company’s analytical software to capture and analyse minute limb and hand movements. The system is CE marked as a Class 1 medical device for diagnosis and monitoring of Parkinson’s disease.
It is the first move into medical equipment for Stabilo. The German company has agreed a deal to make and supply the pens for five years and ensure they meet conform to all relevant European standards for consumer electronics.
Manus was founded in 2008 as a spin-out based on Dr Zietsma’s work in the area of neuroscience and handwriting with Prof Bernard Conway at the University of Strathclyde. In 2018, the business was backed in a seed funding by Par Equity, the Scottish Investment Bank, the University of Edinburgh’s Old College Capital and individual investors including board members.
Read more HERE.
